Glassman Wealth Services Nektar Therapeutics Transaction History

Glassman Wealth Services

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$3.04 - $5.14 $14,932 - $25,247	-4,912 Reduced 99.31%	34 $0
Q2 2022 Aug 04, 2022	BUY	$3.17 - $6.17 $15,536 - $30,239	4,901 Added 10891.11%	4,946 $19,000
Q1 2022 Apr 14, 2022	SELL	$4.16 - $13.72 $124 - $411	-30 Reduced 40.0%	45 $0
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $9,216 - $15,666	-851 Reduced 91.9%	75 $1,000
Q3 2021 Nov 10, 2021	SELL	$13.07 - $18.84 $4,195 - $6,047	-321 Reduced 25.74%	926 $17,000

Q2 2021 Aug 04, 2021	BUY	$16.52 - $20.4 $5,319 - $6,568	322 Added 34.81%	1,247 $21,000
Q1 2021 May 05, 2021	SELL	$16.56 - $25.46 $1,904 - $2,927	-115 Reduced 11.06%	925 $18,000
Q4 2020 Feb 04, 2021	BUY	$15.77 - $19.03 $4,951 - $5,975	314 Added 43.25%	1,040 $18,000
Q3 2020 Nov 09, 2020	BUY	$16.59 - $24.79 $6,868 - $10,263	414 Added 132.69%	726 $12,000
Q2 2020 Aug 06, 2020	BUY	$16.86 - $23.44 $4,923 - $6,844	292 Added 1460.0%	312 $7,000
Q1 2020 May 12, 2020	BUY	$14.47 - $27.96 $289 - $559	20 New	20 $0
Q3 2019 Nov 01, 2019	SELL	$16.91 - $36.27 $135 - $290	-8 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$31.0 - $36.3 $248 - $290	8 New	8 $0
Q1 2019 May 10, 2019	SELL	$31.58 - $46.35 $221 - $324	-7 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$30.43 - $56.65 $213 - $396	7 New	7 $0
Q3 2018 Nov 13, 2018	SELL	$46.46 - $68.49 $232 - $342	-5 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$23.02 - $60.5 $115 - $302	5	5 $0

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.